ATE301834T1 - Verfahren zur bestimmung von antikörpern, die die reverse transkriptase-akitvität hemmen - Google Patents

Verfahren zur bestimmung von antikörpern, die die reverse transkriptase-akitvität hemmen

Info

Publication number
ATE301834T1
ATE301834T1 AT96914441T AT96914441T ATE301834T1 AT E301834 T1 ATE301834 T1 AT E301834T1 AT 96914441 T AT96914441 T AT 96914441T AT 96914441 T AT96914441 T AT 96914441T AT E301834 T1 ATE301834 T1 AT E301834T1
Authority
AT
Austria
Prior art keywords
reverse transcriptase
quantitatively determining
virus
antibodies
antibody
Prior art date
Application number
AT96914441T
Other languages
English (en)
Inventor
Fumitomo Odawara
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Application granted granted Critical
Publication of ATE301834T1 publication Critical patent/ATE301834T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/91245—Nucleotidyltransferases (2.7.7)
    • G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
    • G01N2333/9128—RNA-directed DNA polymerases, e.g. RT (2.7.7.49)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96914441T 1995-05-26 1996-05-24 Verfahren zur bestimmung von antikörpern, die die reverse transkriptase-akitvität hemmen ATE301834T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12790795 1995-05-26
PCT/JP1996/001407 WO1996037781A1 (fr) 1995-05-26 1996-05-24 Methode de dosage d'anticorps inhibant l'activite de la transcriptase inverse

Publications (1)

Publication Number Publication Date
ATE301834T1 true ATE301834T1 (de) 2005-08-15

Family

ID=14971615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96914441T ATE301834T1 (de) 1995-05-26 1996-05-24 Verfahren zur bestimmung von antikörpern, die die reverse transkriptase-akitvität hemmen

Country Status (6)

Country Link
US (1) US5989819A (de)
EP (1) EP0840125B1 (de)
AT (1) ATE301834T1 (de)
CA (1) CA2221769C (de)
DE (1) DE69635052T2 (de)
WO (1) WO1996037781A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9803351D0 (en) * 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
US6630333B1 (en) * 1999-03-23 2003-10-07 Invitrogen Corporation Substantially pure reverse transriptases and methods of production thereof
US20040152072A1 (en) * 2002-07-30 2004-08-05 Invitrogen Corporation Reverse transcription
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
TWI553122B (zh) * 2013-05-21 2016-10-11 Ｓｒｃ公司 用於分子與蛋白質基於螢光之定量偵測的方法與系統

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942122A (en) * 1987-02-24 1990-07-17 Research Education Institute, Inc. Aids prognosis test detecting the presence of antibodies inhibiting HIV reverse transcriptase
JP3011961B2 (ja) * 1989-04-14 2000-02-21 旭化成工業株式会社 逆転写酵素の非放射性基質による測定法
DE69021425T2 (de) * 1989-04-14 1996-04-25 Asahi Chemical Ind Verfahren zur Messung von Reverse-Transcriptase mit nichtradioaktiven Substanzen.
JP3011987B2 (ja) * 1990-10-11 2000-02-21 旭化成工業株式会社 固相化プライマーを用いる逆転写酵素の測定法
JP3011988B2 (ja) * 1990-10-11 2000-02-21 旭化成工業株式会社 固相化プライマーと鋳型ｒｎａとのハイブリダイズ物を用いる逆転写酵素の測定法

Also Published As

Publication number Publication date
EP0840125B1 (de) 2005-08-10
US5989819A (en) 1999-11-23
CA2221769C (en) 2003-07-01
EP0840125A4 (de) 2004-07-21
DE69635052D1 (de) 2005-09-15
EP0840125A1 (de) 1998-05-06
WO1996037781A1 (fr) 1996-11-28
CA2221769A1 (en) 1996-11-28
DE69635052T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
Peluso et al. Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy
Popper et al. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo
NL194922C (nl) Werkwijze voor de bepaling van nucleïnezuren, alsmede set daarvoor.
US7476502B2 (en) Methods and compositions for assaying analytes
Greaney et al. Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
Zhang et al. SARS-CoV-2 detection using quantum dot fluorescence immunochromatography combined with isothermal amplification and CRISPR/Cas13a
Rivas et al. A vertical flow paper-microarray assay with isothermal DNA amplification for detection of Neisseria meningitidis
Carlsson et al. Nucleo-cytoplasmic protein migration during the activation of chick erythrocyte nuclei in heterokaryons
Tasara et al. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other
DE60219813D1 (de) Test-streife-probesystem und verfahren zur nachweis von spezifischen nukleinsäuresequenzen
ATE301834T1 (de) Verfahren zur bestimmung von antikörpern, die die reverse transkriptase-akitvität hemmen
Balbo et al. Measuring protein‐protein interactions by equilibrium sedimentation
Jansen et al. High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay
Yan et al. A one-step fluorescent biosensing strategy for highly sensitive detection of HIV-related DNA based on strand displacement amplification and DNAzymes
Subbramanian et al. Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity
KR101704533B1 (ko) 간암 바이오마커로서의 ＥＲＲγ 및 이의 용도
Wightman et al. Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains
BR0210094A (pt) Método para medir a proporção de expressão de um gene da classe de genes padrões
Chen et al. Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus
Wilber Branched DNA for quantification of viral load
RU2553534C1 (ru) Пара синтетических олигонуклеотидных праймеров для выявления вируса иммунодефицита кошек и способ диагностики вирусного иммунодефицита кошек
US20220307066A1 (en) An enzymatic assay to measure long-term adherence to pre exposure prophylaxis and antiretroviral therapy
ATE290605T1 (de) Verfahren und reagentiensatz zur erkennung von antiviralen wirkstoff resistenzen
Köse et al. Laboratory Diagnosis of HBV
Singla et al. Early detection of SARS-CoV-2 with functionalized gold and molecularly imprinted polymeric nanoparticles: a mini review

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties